PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma
The PaCaReg study is a research project focused on pancreatic ductal adenocarcinoma, which is a common type of pancreatic cancer. It's a 'registry' study, meaning doctors are collecting anonymous information from many different hospitals about people who have just been diagnosed. They want to understand more about the illness itself, like how it starts, how it progresses, and how people are currently being treated. This isn't a study where you'd be given a new drug or treatment; instead, it's about observing and recording what happens naturally. The aim is to gather a lot of practical data that can help doctors learn more about this cancer and potentially improve future care for patients across the UK.
At a glance
What is this study about?
The PaCaReg study is designed to help doctors better understand a specific type of pancreatic cancer called pancreatic ductal adenocarcinoma. This is the most common form of pancreatic cancer. Instead of testing a new treatment, this study is creating a large, secure database of information from people who have been recently diagnosed with this condition across many hospitals.
Think of it like a detailed notebook where doctors record important facts. They'll be looking at various aspects, such as how the cancer was found, what treatments people receive, and how they respond over time. By collecting this information from a large number of patients, researchers hope to identify patterns and learn valuable lessons about the disease in a real-world setting.
The main goal is to improve our knowledge about this challenging cancer. The insights gained from the PaCaReg study could one day help doctors make more informed decisions, develop better treatment plans, and ultimately improve the outlook for future patients with pancreatic ductal adenocarcinoma. It's a way for your experiences, if you choose to take part, to contribute to a bigger picture of understanding.
Key takeaways
- The PaCaReg study collects information about pancreatic cancer.
- It helps doctors understand how the disease affects people in real life.
- You won't get new treatments or extra tests as part of the study.
- Your medical information helps future patients.
- Your privacy is protected, and you can withdraw at any time.
Who may be eligible?
To take part in the PaCaReg study, you would generally need to be an adult, aged 18 or older. Crucially, you must have been recently diagnosed with pancreatic ductal adenocarcinoma, which is the most common type of pancreatic cancer. This diagnosis needs to be confirmed by looking at your cells or tissue under a microscope. In some cases, if doctors are very sure based on other tests and plan to remove the cancer, you might also be able to join.
It's important that you haven't started any treatment for your pancreatic cancer yet. This helps the researchers understand the disease from its early stages. Lastly, you would need to read and sign a consent form, showing you understand the study and agree to participate.
You would not be able to join if you have other, less common types of pancreatic cancer, such as papillary cancer or neuroendocrine pancreatic tumours. This study specifically focuses on pancreatic ductal adenocarcinoma to keep the information consistent.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you recently been diagnosed with pancreatic ductal adenocarcinoma?
- Have you *not* started any treatment for your pancreatic cancer yet?
- Are you willing to sign a consent form?
- Do you *not* have other rare types of pancreatic cancer?
What does participation involve?
This study is a registry, which means it mostly involves collecting information that your doctors already gather as part of your standard care. You wouldn't be asked to change your treatment or have extra medical procedures specifically for the study. Doctors would simply record details about your diagnosis, the treatments you receive, and how you're doing from your existing medical notes.
There are no extra visits to the hospital or specific study appointments required beyond what your regular medical care involves. You won't be given any new medication as part of this study. The researchers will follow your progress by looking at your medical records over time. The total duration of your participation would depend on how long doctors feel it's useful to collect information during your treatment journey, but you can always decide to stop providing your data at any time.
Potential risks and benefits
Locations (1)
- Universitätsklinikum UlmVerified postcodeUlm, Germany· Recruiting
Common questions
What is a 'registry' study?
A registry study collects information about people with a certain condition to learn more about it, without giving new treatments or asking for extra tests.
Will I receive new medicine or treatment by joining?
No, this study is not testing new medicines. Your treatment will be decided by your doctors as usual.
Do I need to go to extra appointments for this study?
No, there are no extra appointments. The study uses information from your regular care.
Will my personal details be kept private?
Yes, great care is taken to keep your information private and anonymous. Your name won't be linked to the data collected.
Can I change my mind after joining?
Absolutely. You can withdraw from the study at any time, and it won't affect your medical care.
How to find out more
Thomas Seufferlein, MD
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.